Prevention of postpartum breast engorgement: double-blind comparison of chlorotrianisene 72 mg. and placebo.
D001941:Breast Diseases / Q000517:prevention & control; D002741:Chlorotrianisene / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D010919:Placebos; D049590:Postpartum Period / Q000187:drug effects*; D011247:Pregnancy
D010919:Placebos; D002741:Chlorotrianisene